UK biotech ‘booming’ as sector rakes in £1.6bn in Q2 financing
pharmaphorum
JULY 6, 2021
The new figures – from the BioIndustry Association and Clarivate – were dominated by more than £1 billion in venture capital funding for UK biotech and life sciences companies, headlined by DNA sequencing company Oxford Nanopore’s £195 million raise in May that was just shy of the £205 million record set by Immunocore in 2005.
Let's personalize your content